PIPELINE

Product
Description
Discovery
Preclinical
Clinical
PNA
*HBV Treatment



anti-Hepatitis B drug (a potential Category 1 drug)

LMGLP
*Immuno-enhancer



new immuno-enhancer drug (a potential Category 1 drug) and alternative drug to cancer treatment

YC-12



Oxazolidinone Antibiotics (a potential Category 1 drug), a drug that is more effective against a broad spectrum of bacterial pathogens, especially Gram-positive drug-resistant bacteria

CO-8




A new drug for the treatment of diabetes

CO-12




A more effective drug for the treatment of drug-resistant tuberculosis

CO-18




An anti-obesity drug used to reduce the risk of cardiovascular disease, metabolic syndrome, high cholesterol and diabetes



Page Updated as at 12/03/08